CD274 and neoplasm: However, up-to-date, the efficacy of a single PD-1/PD-L1 blockade was limited because of many of the intrinsic characteristics of PDAC, including a relatively low tumor mutation burden, a well-established desmoplastic reaction and an immunosuppressive microenvironment.